Drug treatment of migraine: Acute treatment and migraine prophylaxis

Current Opinion in Neurology

Volumn 9, Issue 3, 1996, Pages 211-213

  Tfelt Hansen, Peer ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUTORPHANOL; DIHYDROERGOTAMINE; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; SEROTONIN AGONIST; SUMATRIPTAN; VALPROIC ACID;

CHEMOPROPHYLAXIS; CORONARY ARTERY SPASM; DRUG EFFICACY; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; ORAL DRUG ADMINISTRATION; RECURRENCE RISK; SHORT SURVEY; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX PAIN; TIME;

EID: 0029901682     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199606000-00010     Document Type: Short Survey

References (14)

1. Gross MLP, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H: Sumatrtptan in • acute migraine using a novel cartridge system self-injector. Headache 1994, 34:559-563. The authors demonstrated the feasability of the self-injector for subcutaneous sumatriptan used now in clinical practice.
2. Akpunonu BE, Mutgi AB, Federman DJ, Volinsky FG, Brickman K, Davis RL, Gilbert C, Asgharnejad M: Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department a multicenter study. Ann Emerg Med 1995, 25:464-469.
3. Jensen K, Tfelt-Hansen P, Hansen EW, Krøia EH, Pedersen OS: Introduction • of a novel self-injector for sumatriptan. A controlled clinical trial in general pratice. Cephalalgia 1995, 15:423-429. The feasiblity of the self-injector is demonstrated, as is the efficacy of sumatriptan in migraine patients recruited by general practioners. A very low placebo response of 6% was remarkable.
4. Cutler N, Mushet GR, Davis R, Clements MS, Whricher L: Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology 1995, 45(suppl 7):S5-S9.
5. Sargent J, Kirchner JR, Davis R, Kirkhart B: Oral sumatriptan Is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology 1995, 45(suppl 7):S10-S14.
6. Rederich G, Rapoport A, Cutler N, Hazelrigg R, Jamerson B: Oral •• sumatriptan for the long-term treatment of migraine: clinical findings. Neurology 1995, 45(suppl 7):S15-S20. A large cross-over trial demonstrating the consistency of the efficacy of oral sumatriptan with repeated intake.
7. Tfelt-Hanson P, Henry P, Mulder K, Scheldewaert RG, Schoenen J, Chazot G: •• The effectiveness of combined oral lysine acetylsallcylate and metoclopramlde compared with oral sumatriptan for migraine. Lancet 1995, 346:923-926. The authors demonstrated that a cheaper drug combination can be as effective as oral sumatriptan with a better benefit-risk ratio.
8. Rapoport AM, Visser WH, Cutler NR, Aiderton CJ, Paulsgrove LA, Davis RL, • Ferrari MD: Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology 1995, 45:1505-1509. No effect on headache recurrence rate was found for the combination of subcutaneous and later oral sumatriptan, and the combination is not recommended.
9. O'Connor P, Gladstone P: Oral sumatriptan-associated transmural myocardial infarction. Neurology 1995, 45:2274-2276.
10. Kelly KM: Cardiac arrest following use of sumatriptan. Neurology 1995, 45:1211-1213.
11. Schert ER, Wilson JF: Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995, 35:256-259.
12. The dihydroergotamine nasal spray multicenter investigators: Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Headache 1995, 35:177-184.
13. Hoffert MJ, Couch JR, Diamond S, Elkind AH, Goldstein J, Kohlerman III NJ, • Saper JR, Solomon S: Transnasal butorphanol in the treatment of acute migraine. Headache 1995, 35:65-69. Butorphanol showed some efficacy in the treatment of migraine attacks but its clinical use is hampered by many side effects and its use is not recommended.
14. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, •• Rapoport AM, Silber CJ, Deaton RL: Migraine prophylaxis with divalproex. Arch Neurol 1995, 52:281-286. A well designed study confirming the efficacy of valproate in doses titrated to result in antiepileptic plasma concentrations for migraine prophylaxis.